The endocannabinoid system in cancer-potential therapeutic target?
about
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assayMonoacylglycerol lipase - a target for drug development?A population-based case-control study of marijuana use and head and neck squamous cell carcinomaThe Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.Cannabinoids attenuate cancer pain and proliferation in a mouse modelInhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms.WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells.Cannabidiol inhibits angiogenesis by multiple mechanisms.Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?Roles of Eicosanoids in Prostate Cancer.Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium.Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.Antitumorigenic targets of cannabinoids - current status and implications.Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling.Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells.Revisiting CB1 receptor as drug target in human melanoma.Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.
P2860
Q24654730-401C1692-3582-4A70-B4DA-F6471D575945Q26998964-BAE8ABDE-F09D-4F47-BD9D-5ECA90F5DB2FQ33616287-035DAA36-D2C2-420A-A995-B5C764A00F4DQ33623423-A95E2C2C-0AB9-4DDB-B34A-1081AD453B4DQ34338079-40808A37-AE89-4B36-9F07-AFCF0FDA430CQ34575446-0D770D98-8C3C-4131-98D0-7BAC6BDF29B8Q34667539-C8D21EDF-120D-4B80-933F-18127338AAFFQ34669534-A7F1FF0A-6ADB-4831-A78C-42A3DCF059FDQ34890499-FCF3B37D-D9D2-47F3-8D66-0DB7019C31C4Q34997343-48106935-D773-4247-9B74-2566A5AA7179Q34998169-8874FFB6-3C92-489A-94DF-8D0B34258F75Q35528377-6F20C820-8A4B-4B47-A10D-1E343993533DQ35572084-9D707BA2-A640-43C1-99E4-68F69082AFC8Q36419293-5789A302-6BE1-4DC4-8308-CFC57FFD197DQ36494764-71794F75-3568-4D0B-BB72-DF2EFB4DEC64Q37546194-58914276-7C16-4239-85F9-3F90722E6BDCQ37592857-BE80DC54-BD22-4B57-9420-BDD9291C8AE7Q37625824-1FB803D7-7EEB-4889-A505-AECF4420CE0AQ38351132-A6A9C93C-5D36-482D-8E0D-739880264ED7Q38806270-E0F9B15C-F468-4427-BC0C-FAF7C141D230Q38914267-5CCE2531-F0F7-4C9E-8108-AE9EB83D164AQ38986650-AF5AFB72-22F1-4C78-9523-2D489594220EQ38998620-3583DD94-710F-4434-B713-702150F61668Q39172074-6ED758B6-F297-4E65-A125-A3335C209E82Q39374200-0ECDF8F0-8362-466D-AE22-C681B4453457Q39574967-72851C9C-64F7-44F2-AE63-0D63E2EE47AAQ39663922-9AE7F282-71AA-47F7-82E9-FC7E512C7F6DQ42564268-C5B145DA-B247-4F18-8DAB-463EA50A4171Q55253120-4172C67D-5C4A-4BD6-BEDD-19BC05753FBB
P2860
The endocannabinoid system in cancer-potential therapeutic target?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The endocannabinoid system in cancer-potential therapeutic target?
@en
The endocannabinoid system in cancer-potential therapeutic target?
@nl
type
label
The endocannabinoid system in cancer-potential therapeutic target?
@en
The endocannabinoid system in cancer-potential therapeutic target?
@nl
prefLabel
The endocannabinoid system in cancer-potential therapeutic target?
@en
The endocannabinoid system in cancer-potential therapeutic target?
@nl
P1476
The endocannabinoid system in cancer-potential therapeutic target?
@en
P2093
Birgitta Sander
Jenny Flygare
P304
P356
10.1016/J.SEMCANCER.2007.12.008
P577
2007-12-14T00:00:00Z